Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Shares Sold by Rhumbline Advisers
Rhumbline Advisers decreased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 267,933 shares of the biotechnology company’s stock after selling 2,939 shares during the period. Rhumbline Advisers’ […]
Rhumbline Advisers decreased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 1.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 267,933 shares of the biotechnology company’s stock after selling 2,939 shares during the period. Rhumbline Advisers’ […]
